1)小宮山雅樹:遺伝性出血性毛細血管拡張症.脳卒中の外科43:193-200,2015
2)Dakeishi M, et al:Genetic epidemiology of hereditary haemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19:140-148, 2002
3)Silva BM, et al:Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia. Laryngoscope 123:1092-1099, 2013
4)Merlo CA, et al:The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Int Forum Allergy Rhinol 11:921-925, 2014
5)Faughnan ME, et al:International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48:73-87, 2011
6)Dupuis-Girod S, et al:Hereditary hemorrhagic telangiectasia:from molecular biology to patient care. J Thromb Haemost 8:1447-1456, 2010
7)Hoag JB, et al:An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120:838-843, 2010
8)Begbie ME, et al:Hereditary haemorrhagic telangiectasia(Osler-Weber-Rendu syndrome):a view from the 21st century. Postgrad Med J 79:18-24, 2003
9)Kwaan HC, et al:Fibrinolytic activity in lesions of hereditary hemorrhagic telangiectasia. Arch Dermatol 107:571-573, 1973
10)Geisthoff UW, et al:Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid- a double-blind placebo-controlled cross-over phase ⅢB study. Thromb Res 134:565-571, 2014
11)Gaillard S, et al:Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients:a European cross-over controlled trial in a rare disease. J Thromb Haemost 12:1494-1502, 2014
12)Ross J, et al:The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding:systematic review and meta-analysis of observational studies and randomized trials. Curr Drug Saf 7:44-54, 2012
13)Sautter NB, et al:Hereditary hemorrhagic telangiectasia-related epistaxis:innovations in understanding and management. Int Forum Allergy Rhinol 2:422-431, 2012
14)Richer SL, et al:The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Am J Rhinol Allergy 26:401-404, 2012
15)Ting JY, et al:Management of severe epistaxis after Young's procedure:a case report. Int Forum Allergy Rhinol 3:334-337, 2013
16)Al Kadah B, et al:First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia(HHT). Eur Arch Otorhinolaryngol 272:117-122, 2015
17)Jameson JJ, et al:Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114:705-709, 2004
18)Eivazi B, et al:Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia:an immunohistochemical analysis. Acta Otolaryngol 132:86-89, 2012
19)Sadick H, et al:Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia. Arch Med Res 36:468-473, 2005
20)南 和彦・他:エストリオール軟膏を局所使用したオスラー病例.日鼻誌52:1-7,2013
21)Brinkerhoff BT, et al:Intravenous and topical intranasal bevacizumab(Avastin)in hereditary hemorrhagic telangiectasia. Am J Otolaryngol 33:349-351, 2012
22)Karnezis TT, et al:Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy. Laryngoscope 122:495-497, 2012
23)Boyer H, Fernandes P, Le C, et al Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia. Int Forum Allergy Rhinol 5:435-440, 2015
24)遠藤芳彦:難治性鼻出血例に対するエタノール硬化療法.耳鼻臨床106:699-704,2013
)for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia(HHT):15 years of experience. Rhinology 50:80-86, 2012